macula

My father is age 92, and in 2001 he lost his central vision to macular degeneration.

Or Cochrane review, who say that there is no health effect in case of macula degeneration [3].Also please don't get personal.

If you have a decent or large sized macular degeneration patient population, you'll be doing a lot of these injections.

This form of the disease is caused by abnormal blood vessels growing through the retinal pigment epithelium and damaging the macula.

They're actually pretty common, affecting 5-10% of the population, but unless it crosses your macula, you'll probably never know it happened.

But I was surprised to learn that most of the stuff in our FOV is seen very poorly, and only the tiny area called macula is responsible for the high acuity vision.

Being able to "check the further destruction of the retina" is a therapeutic benefit when it comes to macular degeneration.

Treatment for some forms of age-related macular degeneration used to be limited to one eye, because being blinded is bad, but being blinded in one eye is not as bad.

>Both patients in the trial had "wet" age-related macular degeneration.

And the macula is capable of covering only a small spot in our FOV at one time: what we'd think as a single view is really constructed in a post-processing step as our eyes move and scan our surroundings.

The ophthalmologist I saw shortly after found nothing wrong with my retinas or eye pressure, and declared it a visual migraine and let me go, with a newfound empathy for those with macular degeneration.

Ranibizumab is the generic name of Lucentis, an injection into the eye that is used to treat age-related-macular-degeneration.